Mortality in primary and secondary myocarditis

American Heart Journal

Volumn 147, Issue 4, 2004, Pages 746-750

  Pulerwitz, Todd C ^a,f   Cappola, Thomas P ^b   Felker, G Michael ^c   Hare, Joshua M ^d   Baughman, Kenneth L ^e   Kasper, Edward K ^d  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HAZARD ASSESSMENT; HEMODYNAMICS; HUMAN; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOCARDITIS; PREDICTION; PRIORITY JOURNAL; PUERPERIUM; SYSTEMIC DISEASE;

ADULT; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MYOCARDITIS; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PUERPERAL DISORDERS; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SURVIVAL RATE;

EID: 3142582988     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2003.10.029     Document Type: Article

References (19)

1. Cooper LT, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis - diagnosis and treatment. N Engl J Med 1997;336:1830-6
2. Feldman A.M., McNamara D. Myocarditis. N Engl J Med. 343:2000;1388-1398
3. Lieberman E.B., Hutchins G.M., Herskowitz A., et al. Clinicopathologic description of myocarditis. J Am Coll Cardiol. 18:1991;1617-1626
4. Felker G.M., Thompson R.E., Hare J.M., et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 342:2000;1077-1084
5. McCarthy R.E. III, Boehmer J.P., Hruban R.H., et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. 342:2000;690-695
6. Aretz H.T. Myocarditis The Dallas criteria. Hum Pathol. 18:1987;619-624
7. Cappola T.P., Felker G.M., Kao W.H., et al. Pulmonary hypertension and risk of death in cardiomyopathy Patients with myocarditis are at higher risk. Circulation. 105:2002;1663-1668
8. Felker G.M., Jaeger C.J., Klodas E., et al. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J. 140:2000;785-791
9. Bilgrad R. National Death Index user's manual. Revised ed. Hyattsville, Md: National Center for Health Statistics; February 1995
10. Garg A., Shiau J., Guyatt G. The ineffectiveness of immunosuppressive therapy in lymphocytic myocarditis An overview. Ann Intern Med. 129:1998;317-322
11. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995;333:269-75
12. Unverferth D.V., Baker P.B. Value of endomyocardial biopsy. Am J Med. 80:1986;22-32
13. Dittrich H., Chow L., Denaro F., et al. Human immunodeficiency virus, coxsackievirus, and cardiomyopathy. Ann Intern Med. 108:1988;308-309
14. Beschorner W.E., Baughman K.L., Turnicky R.P., et al. HIV-associated myocarditis. Pathology and immunopathology. Am J Pathol. 137:1990;1365-1371
15. Currie P.F., Jacob A.J., Foreman A.R., et al. Heart muscle disease related to HIV infection Prognostic implications. BMJ. 309:1994;1605-1607
16. Barbaro G., Di Lorenzo G., Grisorio B., et al. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. N Engl J Med. 339:1998;1093-1099
17. Herskowitz A., Wu T.C., Willoughby S.B., et al. Myocarditis and cardiotrophic viral infection with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol. 24:1994;1025-1032
18. Doherty N.E., Siegel R.J. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J. 110:1985;1257-1265
19. Kerr L.D., Spiera H. Myocarditis as a complication in scleroderma patients with myositis. Clin Cardiol. 16:1993;895-899